Devices › Device types
FDA product code KYF · class 2 · Ophthalmic
Implant, eye valve: medical device reports filed with FDA
4,403 reports carry this product code, 1994–2026; 9 brands with a page.
- 4,403
- reports with this product code
- 0% of all MAUDE reports
- 268
- reports, 12 months to August 2026
- 299 in the 12 months before
- 30.3%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code KYF is FDA's classification for "Implant, eye valve" (ophthalmic panel), a class 2 device. 4,403 medical device reports carry this product code, 0% of the MAUDE database, from January 1994 to August 2026.
268 reports arrived in the 12 months to August 2026, down 10% from 299 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (69.5%), malfunction (30.3%) and other (0.2%). 9 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Xen 45 Gts | 1,663 | 88 | 0% | 35.8% |
| Ex-Press Glaucoma Filtration Device | 666 | 11 | 0% | 32.6% |
| Ex-Press Mini Glaucoma Shunt | 552 | 0 | 0% | 37.3% |
| Ahmed Glaucoma Valve | 374 | 29 | 0% | 26.5% |
| Baerveldt Shunt | 345 | 14 | 0% | 19.4% |
| Xen 45 Gts Australia | 207 | 0 | 0% | 8.2% |
| iStent Infinite Trabecular Micro-Bypass System | 178 | 65 | 0% | 30% |
| Istent Inject Trabecular Micro Bypass System | 4 | 0 | 0% | 26.3% |
| Istent Trabecular Micro-Bypass | 1 | 0 | 0% | 18.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Allergan Irvine | 1,936 | 44% |
| Optonol | 1,263 | 28.7% |
| Amo Manufacturing Netherlands | 220 | 5% |
| Glaukos | 184 | 4.2% |
| Johnson & Johnson Surgical Vision | 152 | 3.5% |
| Abbott Medical Optics | 93 | 2.1% |
| Allergan | 8 | 0.2% |
| Alcon Research - Alcon Precision Device | 3 | 0.1% |
| Staar Surgical | 2 | 0% |
| Advanced Medical Optics | 1 | 0% |
| Alcon Laboratories | 1 | 0% |
| Alcon Research / Huntington | 1 | 0% |
| Alcon Research /Huntington | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Complete blockage | 407 | 9.2% |
| Physical resistance/sticking | 345 | 7.8% |
| Malposition of device | 283 | 6.4% |
| Migrationthe device moved from where it was placed | 151 | 3.4% |
| Mechanical jam | 121 | 2.7% |
| Device appears to trigger rejection | 112 | 2.5% |
| Device operates differently than expectedthe device behaved unexpectedly | 112 | 2.5% |
| Fracturea broken bone | 100 | 2.3% |
| Insufficient device problem information | 95 | 2.2% |
| Breakthe device broke | 93 | 2.1% |
| Device dislodged or dislocated | 79 | 1.8% |
| Obstruction of flow | 77 | 1.7% |
| No flow | 74 | 1.7% |
| Failure to deliverthe device did not deliver the dose or item | 68 | 1.5% |
| Partial blockage | 58 | 1.3% |
| Material twisted/bent | 55 | 1.2% |
| Occlusion within devicethe device blocked | 34 | 0.8% |
| Retraction problem | 33 | 0.7% |
| Defective devicethe device was defective | 32 | 0.7% |
| Migration or expulsion of device | 32 | 0.7% |
Questions about implant, eye valve reports
What is product code KYF?
FDA's classification code for "Implant, eye valve", class 2, reviewed by the ophthalmic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
4,403 reports through August 2026, 268 of them in the latest 12 months.
Which brands appear most often?
Xen 45 Gts (1,663), Ex-Press Glaucoma Filtration Device (666), Ex-Press Mini Glaucoma Shunt (552), Ahmed Glaucoma Valve (374) and Baerveldt Shunt (345). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.